{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:50:35Z","timestamp":1794498635703,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clinbiochem.2023.110614","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T03:32:42Z","timestamp":1689737562000},"page":"110614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"118","author":[{"given":"Breanne","family":"Maloney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mycroft","family":"Sowizral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa","family":"Brackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-4863","authenticated-orcid":false,"given":"Roxana","family":"Moslehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-5685","authenticated-orcid":false,"given":"Wendy K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5806-0127","authenticated-orcid":false,"given":"Dorota","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Brower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5813-7064","authenticated-orcid":false,"given":"Michele","family":"Lloyd-Puryear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caggana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7758-820X","authenticated-orcid":false,"given":"Norma P.","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110614_b0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"8639","key":"10.1016\/j.clinbiochem.2023.110614_b0015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(89)92170-3","article-title":"Duchenne muscular dystrophy: neonatal screening and prenatal diagnosis","volume":"333","author":"Plauchu","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110614_b0020","first-page":"55","article-title":"Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus, Genet","volume":"2","author":"Drousiotou","year":"1998","journal-title":"Test."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ejhg.2012.301","article-title":"Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK)","volume":"21","author":"Moat","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12519-017-0036-3","article-title":"Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment","volume":"13","author":"Ke","year":"2017","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/ijns7040077","article-title":"Implementation of hospital-based supplemental Duchenne muscular dystrophy newborn screening (sDMDNBS): A pathway to broadening adoption","volume":"7","author":"Parad","year":"2021","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0040","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/ijns8040050","article-title":"Newborn screening for Duchenne muscular dystrophy: first year results of a population-based pilot","volume":"8","author":"Hartnett","year":"2022","journal-title":"Int. J. Neonatal. Screen."},{"issue":"7","key":"10.1016\/j.clinbiochem.2023.110614_b0045","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1007\/s10072-022-06128-2","article-title":"Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan","volume":"43","author":"Chien","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11071","article-title":"A pilot study of newborn screening for Duchenne muscular dystrophy in Guangzhou","volume":"8","author":"Jia","year":"2022","journal-title":"Heliyon."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.689533","article-title":"Current pharmacological strategies for Duchenne muscular dystrophy","volume":"9","author":"Yao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jnnp.27.2.96","article-title":"Serum enzyme studies in muscle disease. II. Serum creatine kinase activity in muscular dystrophy and in other myopathic and neuropathic disorders","volume":"27","author":"Pearce","year":"1964","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0065","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1373\/clinchem.2016.268425","article-title":"Characterization of a blood spot creatine kinase skeletal muscle isoform immunoassay for high-throughput newborn screening of Duchenne muscular dystrophy","volume":"63","author":"Moat","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/ijns5030027","article-title":"Duchenne muscular dystrophy newborn screening: evaluation of a new GSP\u00ae Neonatal Creatine Kinase-MM Kit in a US and Danish population","volume":"5","author":"Timonen","year":"2019","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0075","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/clinchem\/34.12.2460","article-title":"Activities of creatine kinase and its isoenzymes in serum in various skeletal muscle disorders","volume":"34","author":"Arenas","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","article-title":"Identifying non-Duchenne muscular dystrophy-positive and false negative results in prior Duchenne muscular dystrophy newborn screening programs: A review","volume":"73","author":"Gatheridge","year":"2016","journal-title":"JAMA. Neurol."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.51829","article-title":"Newborn screening for Duchenne muscular dystrophy: a two-year pilot study","author":"Tavakoli","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0090","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.27533","article-title":"Creatine kinase-MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy","volume":"65","author":"Park","year":"2022","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1297\/cpe.11.1","article-title":"Original establishment of reference intervals of thyrotropin and free thyroid hormones during the first week of life","volume":"11","author":"Kawahara","year":"2002","journal-title":"Clin. Pediatric Endocrinol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2023.110614_b0100","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1210\/jc.2002-021732","article-title":"Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value","volume":"88","author":"Olgem\u00f6ller","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/jms.5.1.24","article-title":"Congenital adrenal hyperplasia and early newborn screening: 17 alpha-hydroxyprogesterone (17 alpha-OHP) during the first days of life","volume":"5","author":"Gru\u00f1eiro de Papendieck","year":"1998","journal-title":"J. Med Screen."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0110","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.85.6.1001","article-title":"Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels","volume":"85","author":"Rock","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinbiochem.2023.110614_b0115","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1210\/jc.2004-2136","article-title":"Cutoff Levels of 17-\u03b1-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight","volume":"90","author":"van der Kamp","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0120","first-page":"120","article-title":"TSH levels in relation to gestation, birth weight and sex","volume":"72","author":"Korada","year":"2009","journal-title":"Horm. Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110614_b0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13023-014-0166-9","article-title":"Differences in immunoreactive trypsin values between type of feeding and ethnicity in neonatal cystic fibrosis screening: a cross-sectional study","volume":"9","author":"Cort\u00e9s","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0130","unstructured":"Clinical and Laboratory Standards Institute. Dried blood spot specimen collection for newborn screening. 7th ed. CLSI standard NBS01. Wayne, PA: Clinical and Laboratory Standards Institute; 2021."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/ijns7030040","article-title":"Newborn screening for severe combined immunodeficiency: do preterm infants require special consideration?","volume":"7","author":"Atkins","year":"2021","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clinbiochem.2012.09.013","article-title":"Clinical and environmental influences on metabolic biomarkers collected for newborn screening","volume":"46","author":"Ryckman","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0145","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ajcp\/79.5.582","article-title":"Heterogeneity of serum creatine kinase activity among racial and gender groups of the population","volume":"79","author":"Wong","year":"1983","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjmed.2008.08.033","article-title":"Relationship of ethnic origin, gender, and age to blood creatine kinase levels","volume":"122","author":"Neal","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0155","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2007.06.008","article-title":"Distribution of creatine kinase in the general population: implications for statin therapy","volume":"154","author":"Brewster","year":"2007","journal-title":"Am. Heart J."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004344","article-title":"Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range","volume":"95","author":"George","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinbiochem.2023.110614_b0165","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/jama.1974.03230360025017","article-title":"Elevated creatine phosphokinase levels associated with large muscle mass: another pitfall in evaluating clinical significance of total serum CPK activity","volume":"228","author":"Garcia","year":"1974","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110614_b0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0009-8981(79)90240-7","article-title":"Distribution of serum concentrations of creatine kinase MM and BB isoenzymes measured by radioimmunoassay","volume":"93","author":"Van Steirteghem","year":"1979","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110614_b0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0002-9343(86)90303-7","article-title":"Racial differences in serum creatine kinase levels","volume":"81","author":"Black","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0180","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ejhg.2012.269","article-title":"Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age","volume":"21","author":"Mercier","year":"2013","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajmg.c.32000","article-title":"Newborn screening for Duchenne muscular dystrophy-early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy","volume":"190","author":"Gruber","year":"2022","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0190","doi-asserted-by":"crossref","first-page":"8396429","DOI":"10.1155\/2020\/8396429","article-title":"Population-wide Duchenne muscular dystrophy carrier detection by CK and molecular testing","author":"Han","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.clinbiochem.2023.110614_b0195","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1542\/peds.38.6.1039","article-title":"Creatine phosphokinase activity in serum of newborn infants as an indicator of fetal trauma during birth","volume":"38","author":"Rudolph","year":"1966","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinbiochem.2023.110614_b0200","first-page":"397","article-title":"Utilization of capillary blood for serum enzyme analysis","volume":"25","author":"Bodensteiner","year":"1970","journal-title":"Helv. Paediatr. Acta."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110614_b0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00431-016-2814-7","article-title":"The influence of seasonality and manufacturer kit lot changes on 17\u03b1-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns","volume":"176","author":"Pearce","year":"2017","journal-title":"Eur. J. Pediatr."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202300142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991202300142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:02:41Z","timestamp":1757865761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991202300142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":41,"alternative-id":["S000991202300142X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110614","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Wadsworth Center, New York State Department of Health. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110614"}}